• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Activity of various glycopeptides against an inducibly vancomycin-resistant strain of Enterococcus faecium (D366).

作者信息

Shlaes D M, Al-Obeid S, Shlaes J H, Williamson R

机构信息

Laboratoire de Microbiologie Médicale, Université de Paris VI, France.

出版信息

J Infect Dis. 1989 Jun;159(6):1132-5. doi: 10.1093/infdis/159.6.1132.

DOI:10.1093/infdis/159.6.1132
PMID:2524533
Abstract
摘要

相似文献

1
Activity of various glycopeptides against an inducibly vancomycin-resistant strain of Enterococcus faecium (D366).多种糖肽类药物对屎肠球菌诱导型耐万古霉素菌株（D366）的活性。
J Infect Dis. 1989 Jun;159(6):1132-5. doi: 10.1093/infdis/159.6.1132.
2
Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.粪肠球菌中质粒介导的对万古霉素和替考拉宁的耐药性
N Engl J Med. 1988 Jul 21;319(3):157-61. doi: 10.1056/NEJM198807213190307.
3
Transferable vancomycin and teicoplanin resistance in Enterococcus faecium.粪肠球菌中可转移的万古霉素和替考拉宁耐药性
Antimicrob Agents Chemother. 1989 Jan;33(1):10-5. doi: 10.1128/AAC.33.1.10.
4
Inducible carboxypeptidase activity in vancomycin-resistant enterococci.耐万古霉素肠球菌中的诱导型羧肽酶活性。
Antimicrob Agents Chemother. 1992 Jan;36(1):77-80. doi: 10.1128/AAC.36.1.77.
5
[The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].替考拉宁和万古霉素对革兰氏阳性微生物的体外活性（校正后）
Mikrobiyol Bul. 1991 Oct;25(4):321-5.
6
Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.LY146032（达托霉素）对革兰氏阳性球菌的体外活性比较
Eur J Clin Microbiol. 1987 Feb;6(1):96-9. doi: 10.1007/BF02097210.
7
A comparison of the responses of staphylococci and streptococci to teicoplanin and vancomycin.葡萄球菌和链球菌对替考拉宁和万古霉素反应的比较。
J Antimicrob Chemother. 1987 Aug;20(2):155-64. doi: 10.1093/jac/20.2.155.
8
Inducible resistance to vancomycin in Enterococcus faecium D366.粪肠球菌D366对万古霉素的诱导性耐药
J Infect Dis. 1989 Jun;159(6):1095-104. doi: 10.1093/infdis/159.6.1095.
9
Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus faecalis A256.粪肠球菌D366和屎肠球菌A256对万古霉素的耐药机制。
Antimicrob Agents Chemother. 1990 Feb;34(2):252-6. doi: 10.1128/AAC.34.2.252.
10
Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis.粪肠球菌和屎肠球菌中万古霉素耐药性的特征分析
Antimicrob Agents Chemother. 1989 Jul;33(7):1121-4. doi: 10.1128/AAC.33.7.1121.

引用本文的文献

1
Enterococcal resistance to vancomycin and related cyclic glycopeptide antibiotics.肠球菌对万古霉素及相关环脂肽类抗生素的耐药性。
Eur J Clin Microbiol Infect Dis. 1990 Feb;9(2):106-10. doi: 10.1007/BF01963634.
2
Resistance to vancomycin and teicoplanin: an emerging clinical problem.对万古霉素和替考拉宁的耐药性：一个新出现的临床问题。
Clin Microbiol Rev. 1990 Jul;3(3):280-91. doi: 10.1128/CMR.3.3.280.
3
Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus faecalis A256.粪肠球菌D366和屎肠球菌A256对万古霉素的耐药机制。
Antimicrob Agents Chemother. 1990 Feb;34(2):252-6. doi: 10.1128/AAC.34.2.252.
4
Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United States.两种新型替考拉宁酰胺衍生物（MDL 62211和MDL 62873）与替考拉宁和万古霉素对来自法国和美国的800株近期葡萄球菌分离株的活性比较。
Antimicrob Agents Chemother. 1991 Mar;35(3):584-6. doi: 10.1128/AAC.35.3.584.
5
In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile.雷莫拉宁和四种糖肽类抗生素对艰难梭菌临床分离株的体外活性
Antimicrob Agents Chemother. 1991 Jan;35(1):195-7. doi: 10.1128/AAC.35.1.195.
6
In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.替考拉宁的三种半合成酰胺衍生物MDL 62208、MDL 62211和MDL 62873的体外活性
Antimicrob Agents Chemother. 1992 Feb;36(2):331-8. doi: 10.1128/AAC.36.2.331.